Generic Name: Edoxaban
Brand Name: Lixiana NVAF
Manufacturer: Daiichi Sankyo, Inc.
Indications: Nonvalvular atrial fibrillation, prevention of stroke and systemic embolism
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: March 21, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions